Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 15:417:117076.
doi: 10.1016/j.jns.2020.117076. Epub 2020 Aug 5.

Liver abnormality may develop cerebral vein thrombosis in COVID-19

S Aghayari Sheikh Neshin  1 , S Basirjafari  2 , A Saberi  1 , B Shahhosseini  3 , M Zarei  4
Affiliations
Comment

Liver abnormality may develop cerebral vein thrombosis in COVID-19

S Aghayari Sheikh Neshin et al. J Neurol Sci. .
No abstract available

Keywords: COVID-19; CVST; Liver abnormality.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A-B, non-contrast lung CT scan at two cross-sections exhibits multilobar areas of ground-glass opacity (GGO) in the peripheral and subpleural band (red arrowhead) in favor of COVID-19. C-D, non-contrast brain CT scan demonstrates increased density within straight sinus (red arrowhead) and superior sagittal sinus (green arrow). E, axial FLAIR image shows hyperintensity involving the bilateral thalami (most prominent in the left-side) and bilateral basal ganglia (green arrowhead). Findings were compatible with thrombosis of superior sagittal sinus, straight sinus, both internal cerebral veins and left transverse sinus (red arrowhead). F, coronal T1 weighted image shows hyperintensity at both internal cerebral veins in favor of thrombosis (red arrow). G-H, axial T1 weighted images show lack of signal void at superior sagittal sinus and after GAD injection at the same image, the thrombosis is more visible (red arrowhead). I, hyperintensity at left temporal lobe in favor of venous infarction (green arrowhead), (J) MR venography demonstrates the absence of normal flow-related signal within the deep cerebral veins. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
See this image and copyright information in PMC

Comment on

  • Venous cerebral thrombosis in COVID-19 patient.
    Garaci F, Di Giuliano F, Picchi E, Da Ros V, Floris R. Garaci F, et al. J Neurol Sci. 2020 Jul 15;414:116871. doi: 10.1016/j.jns.2020.116871. Epub 2020 May 1. J Neurol Sci. 2020. PMID: 32422428 Free PMC article. No abstract available.

References

    1. Garaci F., Di Giuliano F., Picchi E., Da Ros V., Floris R. Venous cerebral thrombosis in COVID-19 patient. J. Neurol. Sci. 2020 Jul 15;414:116871. doi: 10.1016/j.jns.2020.116871. Epub 2020 May. - DOI - PMC - PubMed
    1. Cai Q., Huang D., Yu H. COVID-19: Abnormal liver function tests. J. Hepatol. 2020;73(3):566–574. doi: 10.1016/j.jhep.2020.04.006. - DOI - PMC - PubMed
    1. Wander P., Epstein M., Bernstein D. COVID-19 presenting as acute hepatitis. Am. J. Gastroenterol. 2020;115(6):941–942. doi: 10.14309/ajg.0000000000000660. - DOI - PMC - PubMed
    1. Folsom A.R., Lutsey P.L., Roetker N.S. Elevated hepatic enzymes and incidence of venous thromboembolism: a prospective study. Ann. Epidemiol. 2014;24(11):817–821. e2. doi: 10.1016/j.annepidem.2014.08.004. - DOI - PMC - PubMed
    1. Galli L., Gerdes V.E., Guasti L., Squizzato A. Thrombosis associated with viral hepatitis. Journal of Clinical and Translational Hepatology. 2014 Dec;2(4):234–239. doi: 10.14218/jcth.2014.00031. - DOI - PMC - PubMed